Rating Change
BTIG analysts reiterated a Buy rating on Guardant Health, Inc. (NASDAQ:GH) on July 01, 2026.
reiterateNASDAQ:GH
BTIG Reiterates Buy Rating on Guardant Health, Inc. (GH)
Rating Change BTIG analysts reiterated a Buy rating on Guardant Health, Inc. (NASDAQ:GH) on July 01, 2026. Market Context Guardant Health, Inc.
Market Context
Guardant Health, Inc. operates in the Healthcare sector. The stock currently trades at $170.77 with a market capitalization of $12.6B. The stock has gained 195.0% over the past 52 weeks.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Guardant Health, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Guardant Health, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 01, 2026 | BTIG | Buy | N/A |
| Jun 29, 2026 | Guggenheim | Buy | N/A |
| Jun 26, 2026 | Bernstein | Outperform | N/A |
| Jun 24, 2026 | Barclays | Overweight | N/A |
| Jun 11, 2026 | RBC Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View GH Stock Page
Frequently Asked Questions
What does a Buy rating mean for GH?
A Buy rating from BTIG reflects the analyst's outlook on Guardant Health, Inc. (NASDAQ:GH). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the GH forecast page.